Related Experiment Videos
Structure modification in knee osteoarthritis: methodology and outcome parameters
1Nutramax Laboratories, Inc., Baltimore, Maryland, USA.
Osteoarthritis and Cartilage
|July 27, 2001
Summary
Structure-modifying agents (SMAs) offer a promising approach to managing osteoarthritis (OA). Optimizing clinical trials for SMAs requires careful selection of outcome measures, imaging techniques, and patient populations for accurate efficacy assessment.
Area of Science:
- Rheumatology
- Pharmacology
- Medical Imaging
Background:
- Osteoarthritis (OA) management is evolving with a focus on structure-modifying agents (SMAs).
- SMAs represent a promising therapeutic avenue for OA, gaining interest from patients and healthcare professionals.
- Assessing the efficacy of SMAs requires robust methodologies to evaluate their impact on OA progression.
Purpose of the Study:
- To review methodologies for assessing the structure-modifying potential of OA interventions.
- To identify key outcome parameters and assessment techniques for SMA trials.
- To provide guidance for designing effective SMA studies.
Main Methods:
- A comprehensive Medline search was conducted to identify relevant published articles.
- The review focuses on the methodology and outcome parameters used in SMA research.
- Detailed study design aspects are referenced, with a vast number of relevant articles provided for further reading.
Main Results:
- Feasibility of SMA trials can be enhanced by optimizing outcome parameters, imaging methods, and patient selection.
- Careful consideration of these factors is crucial for investigators planning SMA studies.
- The article addresses critical issues for designing structure-modifying studies.
Conclusions:
- Radiographic techniques are currently favored for measuring joint space narrowing in homogeneous OA populations.
- Further research is needed to establish the reliability of alternative imaging modalities like ultrasound, chondroscopy, and MRI.
- Standardized and validated methods are essential for evaluating SMA efficacy.